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1. Introduction  
Lygodium is the dry root and rhizome of Lygodium japonicum (Thunb.)Sw. which belongs to 
the family Lygodiaceae. Lygodium is the only genus of Lygodiaceae comprises 45 species 
throughout the world. In China, there are 10 species of Lygodium distributed in the 
southwest and south China, and five species of them had been used for Chinese herbs 
medicine to treat hepatitis and dysentery[1]. They are named Lygodium, Lygodium of 
hainan, Crankshaft Lygodium, Angustifolia Lygodium, Pinnately lobed Lygodium, Willow-
like leaves Lygodium, Reticulata Lygodium, yunnan Lygodium, Lobular Lygodium, Palm 
leaf Lygodium.  
 
 
 
 
Fig. 1. Leaves and branches of Lygodium japonicum (Thunb.)Sw.  
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Fig. 2. Dried powder of Lygodium japonicum (Thunb.)Sw.  
2. Chemical composition 
Currently, the research on the active components in the Lygodium were done on the 
underground parts. We summarize the structure and classification of these compounds 
from lygodium. 
2.1 The main components of the Lygodium root[3] 
2.1.1 Ecdysteroside  
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Capitasterone-3-O-β-D-glucopyranoside Lygodiumsteroside A* 
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Lygodiumsteroside B* Makisterone C 
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2.1.2 Triterpenes 
O
COOH
HO
HO
 
Friedelin 2α-hydroxyursolic acid 
2.1.3 Flavonoids 
O
O
OH
O
O
OH
Rha
Rha
 
Kaempferol-3-O-α-L- rhamnopyranoside-7-O-α- L-rhamnopyranoside 
2.1.4 Phytosterols 
 
OH
HO  
22-hydroxyhopane β-phytosterol
Glc-O  
Daucosterol 
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2.1.5 Glycosides 
COOH
OH
OO
OH
OH
OMe
HO
 
3,4-dihydroxybenzoic acid 4-O- (4′-O-methyl)-β -D-glucopyranoside 
2.1.6 Organic acids 
COOH
COOH  
HOOC
COOMe
OH
 
Succinic acid Methylmalic acid 
2.1.7 Naphthoquinone  
O
O
HO
H3C
CH3
CH3  
2-isopropyl-7-methly-6-hydroxy-α-(1,4) naphthoquinone* 
2.2 The main components of the root of Lygodium from n-butanol layer[2][3] 
2.2.1 flavonoids 
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Linaribn Dosinin 
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Nicotflorin Tilianine 
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Kaempferol- ǂ Kaempferol-1-rhamnopyranoside 
2.2.2 Phenylpropanoids 
HO
HO
O
OH
HO
COOH
 
Caffeic acid P-coumaric acid 
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6-O-p-coumaroyl-D-glucopyranose 6-O-caffeoyl-D-glucopyranose 
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2.2.3 Phenolic acids[4]  
COOH
OH
OO
OH
OH
OMe
HO
COOH
OCH3
OH  
3,4-Dihydroxybenzoic acid 4-O- 
(4’-O-methyl)-ǃ-D-glucopyranoside 
Vanillic acid 
2.2.4 Sterols 
A new steroidal saponins was Isolated from the root of Lygodium, which is (24- R)-
stigmastan-3┚, 5┙,6┚-triol-3-O-┚-D-glucopyranoside, in addition to daucostero1 and  
ǃ-sitostero1.  
2.2.5 Others 
Hexadecanoic acid 2, 3-dihydroxy, propyl ester, hexacosanoic acid, 1-hentriacontano1, 
pentacosanoic acid, palmitic acid, linoleic acid, (6S, 9R) -6 - hydroxy -3- ketone - Violet 
alcohol-D-β-9-O-glucoside (roseoside) and so on. 
2.2.6 Diterpenoids 
 
H
H
CH2
HH
O
OC
COOCH3
H
H
O
OC
COOCH3  
Gibberellin A9 methyl ester Gibberellin A73 methyl ester 
H
H
CO2CH3
H
H
H
H
CH2
OHH
O
OC
COOCH3  
Gibberellin A12 methylester GA20-Me 
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H
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COOCH3
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H
H
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COOCH3
HO
H
 
12α-hydroxy GA9-Me 12┚-hydroxy GA9-Me 
3. New compounds from Lygodium japonicum  
3.1 New naphthalene ketone from the root of Lygodium japonicum[5] 
3.1.1 Extraction and isolation 
Air-dried roots of L. japonicum (Thunb.) Sw.(4 kg) were crushed and extracted twice under 
reflux with 70% EtOH. Evaporation of the solvent under reduced pressure delivered the 
70% EtOH extract (around 280 g). The extract was partitioned successively with CHCl3, 
AcOEt and n-BuOH. The n-BuOH-soluble fraction(50.0 g) was further eluted on a silica 
gel column using gradient elution with CHCl3–MeOH (100:1–1:1) to give ten fractions. 
Fraction 2 (2.3 g) was subjected to another silica gel column chromatography eluted with 
petroleum ether (PE)–EtOAc (20:1–1:1) to afford a further five fractions (frs. 2-1 to 2-5). 
Fraction 2-2 was purified twice by Sephadex LH-20 eluted with MeOH to give the new 
compound 1(9mg). 
3.1.2 Apparatus 
Melting points were determined on an X4-A micro-melting point apparatus and were 
uncorrected. ESI–MS spectra were measured on an Agilent 1100 LC-MSD-Trap-SL, and HR–
ESI–MS spectra were measured on an Bruker Dal- tonics MicroTOFQ. NMR spectra were 
measured on a Bruker ARX-600 and 300 NMR spectrometer with tetra-methylsilane (TMS) 
as the internal reference and chemical shifts are expressed with δ (ppm). UV spectra were 
recorded on a Shimadzu UV-2201 spectrometer. IR spectra were recorded on a Bruker IFS-55 
spectrophotometer. TLC was performed on silica gel GF254 (10–40 lm; Qingdao,China). 
Separations were performed by Semiprep-HPLC named Shimadzu SPD-10A apparatus 
equipped with UV detector under ODS column (i.d. 10 mm 9 200 mm). 
3.1.3 Physical data of the new compound 1 
The new compound,yellow powder, melting point:193–194℃. The molecular formula was 
determined as C14H14O3 by HR–ESI–TOF–MS (m/z 231.1004[M + H]+, calcd. 231.1016), along 
with 1H-NMR and 13C-NMR data. The UV spectrum displayed absorption bands at 207, 267 
and 347 nm, closely resembling that of 1,4-naphthoquinones. The 13C-NMR spectrum revealed 
14 carbon resonances; in the low field area of it, two were assigned as carbonyl carbons, eight 
were assigned as aromatic carbons. However, in the high field area of 13C-NMR spectrum, 
there were four carbon resonances all that assigned as sp3 carbons. By observing these data of 
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13C-NMR spectrum, nucleus of naphthoquinone was revealed. All protonated carbons were 
assigned by analysis of the HSQC spectrum (Table 1).The 1H-NMR spectrum showed signals 
of two aromatic protons atδ7.30 (1H, s, H-5), 7.77 (1H, s, H-8) and one aromatic methyl proton 
at d 2.24 (3H, s, 7-CH3) that were assigned by analyzing HMBC spectrum (Table 1; Fig. 1). 
Additionally, δ1.12 (6H, d, J = 6.8 Hz,H-12, H-13) and 6.68 (1H, s, H-3) correlated, 
respectively, with d: δ26.6 (C-11), δ156.6 (C-2) in the HMBC spectrum and δ 3.09 (1H, m, H-
11) correlated with δ21.4(C-12 and 13), 156.6 (C-2), 131.6 (C-3), 183.4 (C-1) all that revealed the 
presence of isopropyl and it connected C-2 of quinone ring. Other detailed correlations in the 
HMBC spectrum see Table 1. All these spectroscopic data discussed above showed compound 
1 as 6-hydroxy-2-isopropyl-7-methyl-1,4- naphthoquinone. 
 
C No. HSQC  HMBC 
 δC δH, mult  
1 183.5   
2 156.6   
3 131.6 6.68 (1H, s) C2/C11 
4 185.2   
5 110.3 7. 30 (1H, s) C6/C9/C4 
6 160.9   
7 131.8   
8 129.5 7. 77 (1H, s) C1/C10/C7 (CH3)/C6 
9 124.1   
10 131.7   
CH3-7 16.2 2.24 (3H, s) C6/C8 
11-CH- 26.6 3.09 (1H, m) C12/ C13/C2 
12-CH3 21.4 1.13 (6H, d, J=6.8 Hz) C11/C2 
13-CH3 21.4 1.11 (6H, d, J=6.8 Hz ) C11/C2 
Table 1. 1H and 13C data for New naphthalene ketone (300and 75MHz,in DMSO- d6). 
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Fig. 3. The key HMBC correlations of the new compound 1. 
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3.2 The new compound 2 from the roots of Lygodium japonicum[6] 
OH
OH
HO
O
O
OH
Glc
 
lygodiumsteroside B 
3.2.1 Extraction and isolation 
The air-dried roots of L. japonicum (Thunb.) Sw were crushed and extracted twice using 
reflux with 70% ethanol; the solution was concentrated under reduced pressure to obtain the 
residue, and then the residue was extracted with MeOH. The MeOH-soluble fraction (100 g) 
was isolated by column chromatography on silica gel and gradient elution with 
CHCl3:MeOH (50 : 1 to 1 : 1) gave 14 fractions. Fraction 8 was isolated by semipreparative 
ODS column using MeOH:H2O (65 : 35) as eluent to afford the new compound 2 (13mg). 
3.2.2 Apparatus 
Melting point: X-4 micro melting point determination apparatus (uncorrected). ESI–MS 
spectra: LC–MSD-Trap-SL. HR–ESI–MS spectra: Bruker MicroTOFQ.1H NMR(600MHz) and 
13 C NMR (150MHz): Bruker ARX- 600. UV: Shimadzu UV 260 UV–Vis. Semiprep-HPLC: 
Shimadzu SPD-10A apparatus equipped with UV detector under ODS column (i.d. 
10mm*200mm). 
3.2.3 The spectrum of new compound  
1. 1H-NMR and 13C-NMR data for the new compound 2 
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HO
O
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Fig. 4. The key HMBC correlations of the new compound 2. 
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C HMQC HMBC 
δC(ppm) δH(ppm) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
C-1’ 
C-2’ 
C-3’ 
C-4’ 
C-5’ 
C-6’ 
38.7 
67.5 
77.7 
30.6 
51.4 
203.0 
121.7 
166.3 
34.3 
39.1 
21.1 
32.0 
48.1 
84.2 
31.9 
21.4 
50.0 
18.0 
24.1 
76.9 
21.6 
74.2 
36.9 
35.6 
33.7 
20.3 
18.7 
15.2 
104.2 
74.7 
78.7 
71.6 
78.5 
62.6 
1.74(brd, J=12.6Hz), 2.02(m) 
4.07(br.dt, J=10.8 Hz), 
4.28(brs) 
1.65, 2.20(each m) 
2.93(m) 
 
6.23(brs) 
 
3.53(t, J=8.4 Hz) 
 
1.67, 1.80(each m) 
2.02(m),2.58(dt, J=4.2 and 12.6 Hz)
 
 
1.92, 2.17(each m) 
2.08, 2.45(each m) 
2.89(m) 
1.20(s) 
0.88(s) 
 
1.58(s) 
3.90(m) 
1.45, 1.63(each m) 
1.93(m) 
1.46(m) 
0.80(d, J=6.6 Hz) 
0.76(d, J=6.6 Hz) 
0.83(d, J=6.6 Hz) 
4.92(d, J=7.8 Hz) 
4.03(overlap) 
4.20(overlap) 
4.21(m) 
3.92(m) 
4.32(m),4.52(brd, J=10.8 Hz) 
C-2,C-3,C-9,C-10,C-19 
 
 
 
C-4,C-9 
 
C-5,C-9,C-14 
 
 
 
C-8,C-9,C-12,C-13 
C-9,C-11,C-18 
 
 
C-13,C-16 
C-17 
C-13,C-15,C-16,C-18 
C-12,C-13,C-14,C-17 
C-1,C-2,C-5,C-10 
 
C-17, C-20, C-22 
C-20 
C-21,C-24,C-28 
 
C-23,C-26,C-27 
C-24,C-25,C-27 
C-24,C-25,C-26 
C-23,C-24,C-25,C-27 
C-3 
C-3′ 
C-2′, C-4′ 
C-5′, C-6′ 
C-4′, C-5′ 
C-4′, C-5′ 
Table 2. 1H and 13C NMR data for lygodiumsteroside B (600 and 150 MHz, in C5D5N). 
2. Other spectrum data for the new compound 2 
The new compound 2(lygodiumsteroside B): white powder, m.p. 294–295℃ ,UV max 
(MeOH): 243 nm; ESI–MS:m/z 675.5 [M+Cl]-, m/z 639.7 [M+H]+; HR–ESI–MS: m/z 639.3701 
[M+H]+(Calcd forC34H55O11 639.3750);1H-NMR (600MHz, in C5D5N) and 13C-NMR 
(150MHz, inC5D5N), see table 2 . 
www.intechopen.com
 The Research of Lygodium 
 
87 
3. NMR Analysis of the new compound 2 
Lygodiumsteroside B, white powder, m.p. 294–295℃, gave positive responses to 
Liebermann–Burchard and Molish reactions, which suggested a steroid glycoside structure. 
The sugar was identified as glucose by co-TLC with authentic sample after acid hydrolysis. 
The molecular formula was established to be C34H56O11 based on HR–ESI–MS([M+H]+,m/z 
639.3701, Calcd for C34H55O11 639.3750). Additionally, the UV spectrum showed a maximum 
at243 nm[Check this typing] for an͉,͊-unsaturated carbonyl group.The1H 
NMR(600MHz,C5D5N) spectrum showed an olefinic proton at δ6.23 (1H,brs) and six 
methyl signals atδ1.58 (3H, s), 1.20 (3H, s), 0.88 (3H, s), 0.83(3H, d, J¼6.6Hz), 0.80 (3H, d, 
J¼6.6Hz), 0.76 (3H, d, J¼6.6Hz). The13C –NMR (150MHz,C5D5N) spectrum showed six 
methyl signals and a typical͉, ͊-unsaturated carbonyl group signals at δ 203.0 (C-6), 
166.3 (C-8) and 121.7 (C-7). The HMBC spectrum, showed the long-range correlations 
betweenδ 6.23 (1H, brs, H-7) andδ 34.3(C-9), 51.4 (C-5), 84.2 (C-14), the correlations 
between methyl proton signal at δ 0.88 (3H, s,H-19) and the carbon signals at δ38.7 (C-1), 
39.1 (C-10), 51.4 (C-5) and 67.5 (C-2) could also be observed. In addition, the correlations 
between methyl proton signal at δ1.20 (3H, s,H-18) and the carbon signals at δ 32.0 (C-12), 
48.1 (C-13), 50.0 (C-17) and 84.1(C-14) could also be found. Thus, the ecdysteroid-type 
skeleton was identified. In the HSQC spectrum, δ 4.07 (1H, brd, H-2) had the correlation 
withδ 67.5 (C-2) and δ 4.28(1H, brs, H-3) had the correlation with (1H, brs, H-3) had the 
correlation with (1H, brs, H-3) had the correlation with(1H, brs, H-3) had the correlation 
withδ77.7 (C-3). δ1.58 (3H, s,H-21) showed the correlation withδ50.0 (C-17), δ 74.2 (C-22 
and δ76.9 (C-20) in the HMBC. So the signals of the five hydroxyl carbons C-2, C-3, C-14, C-
20, C-22 were evident. Additionally, δ0.83 (3H, d,H-28) showed correlation withδ1.93 
(1H,m,H-24) in the1H–1H COSY, and the HMBC spectrum showed the correlations 
betweenδ0.83 (3H, s,H-28) andδ18.7 (C-27),33.7 (C-25), 35.6 (C-24), 36.9 (C-23). These facts 
indicated that a methyl group (C-28) was attached to C-24. 
Compared with polyporusterone A (Ishida et al., 1999; Ohsawa, Yukama, Takao,Murayama, 
& Bando, 1992), the chemical shifts of C5–C22 were very similar; this fact suggested that the 
positions of the substituents on the steroid rings and side-chain of the new compound were 
identical with polyporusterone A except for C24, and the configuration of hydroxyls were 
14͉,20R,22R. Since the signals at 33.7 (C-25), 20.3 (C-26), 18.7 (C-27) were different from the 
corresponding values of polyporusterone A, the configuration of C-24 could be different. 
Compared with the compound schizaeasterone A (Fuchino et al., 1997), which has 24R 
configuration, the chemical shifts of C20–C28 were very similar to those of schizaeasterone 
A. Moreover, in the NOESY spectrum, a cross peak was observed betweenδ3.91 (1H, 
overlap, H-22) andδ0.83 (3H, d,H-28). So all these facts indicated that the configuration of 
C-24 of compound 1 was R (Figure 2). The NOESY spectrum also showed the correlation 
between the proton signal atδ4.07 (1H, brd, H-2) andδ4.28 (1H, brs, H-3), δ1.65 
(1H,m,H͉-4), so the relative configuration was confirmed to be2͊,3͊.  
Since the signal at δ77.7, which could assignable to C-3, was downfield shifted by 9 ppm, 
and the signal atδ30.6 (C-4) was upfield shifted, glycosylation was present atC-3. The 
chemical shifts of the sugar moiety in 13C -NMR (δ104.2, 74.7, 78.7, 71.6, 78.5,62.6) also 
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confirmed the presence of glucose. The HMBC correlation was observed between the 
anomeric proton signal at δ4.92 (1H, d,H-10) and the carbon signal atδ77.7due to C-3 of 
the aglycone moiety. The anomeric configurations of glucose were determined to be on the 
basis of the JH–H values (J¼7.8Hz).Therefore, the structure of 2 was elucidated as 
2͊,3͊,14͉, 20R, 22R - pentahydroxy-24R-methly-5-cholest-7-en-6-one-3-O-͊-D-
glucopyranoside, and named lygodiumsteroside B  
 
C No. HMQC HMBC 
δC(ppm) δH(ppm) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
C-1′ 
C-2′ 
C-3′ 
C-4′ 
C-5′ 
C-6′ 
38.7 
67.5 
76.8 
30.3 
51.4 
203.1 
121.7 
166.4 
34.3 
39.0 
21.1 
32.0 
48.1 
84.2 
31.8 
21.5 
50.1 
17.9 
24.1 
77.7 
21.6 
76.8 
28.2 
37.2 
30.6 
23.4 
22.4 
104.2 
74.7 
78.7 
71.6 
78.5 
62.6 
1.76(m), 2.10(m) 
4.10(br.dt, J=11.4 Hz), 
4.30(overlap) 
1.73, 2.20(each m) 
2.93(m) 
 
6.23(d, J=1.8 Hz) 
 
3.55(t, J=8.4 Hz) 
 
1.65, 1.83(each m) 
2.02(m),2.58(dt, J=4.2 and 12.6 Hz) 
 
 
1.92, 2.15(each m) 
2.08, 2.44(each m) 
2.91(m) 
1.19(s) 
0.87(s) 
 
1.58(s) 
3.81(brd, J=10.8 Hz) 
1.47(m) 
1.40, 1.70(each m) 
1.54(m) 
0.81(d, J=6.0 Hz) 
0.82(d, J=6.0 Hz) 
4.90(d, J=7.8 Hz) 
4.03(m) 
4.20(m) 
4.18(m) 
3.93(m) 
4.32(m),4.53(brd, J=10.2 Hz) 
C-2,C-3,C-9,C-10,C-19 
 
 
C-1,C-5,C-9,C-19 
C-1,C-4,C-6,C-9 
 
C-5,C-9,C-14 
 
C-1,C-11,C-19 
 
C-8,C-9,C-13 
C-11,C-13,C-17,C-18 
 
 
C-13,C-16 
C-17 
C-11,C-13,C-15,C-18,C-22 
C-12,C-13,C-14,C-17 
C-1,C-2,C-5,C-9 
 
C-17,C-22,C-23 
C-21,C-24 
C-21,C-24,C-25,C-26,C-27 
C-23,C-26,C-27 
 
C-23,C-24,C-27 
C-23,C-24,C-26 
C-3 
C-3′ 
C-2′, C-4′ 
C-5′, C-6′ 
C-4′, C-5′ 
C-4′, C-5′ 
Table 3. 1H and 13C NMR data for polyporusterone A (600 and 150 MHz, in C5D5N). 
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4. Attached figure: 
 
Fig. 5. Lygosteroside B (1H-NMR). 
  
Fig. 6. Lygosteroside B (1H-NMR). 
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Fig. 7. Lygosteroside B (HSQC).  
 
Fig. 8. Lygosteroside B (HSQC). 
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Fig. 9. Lygosteroside B (HMBC).  
 
Fig. 10. Lygosteroside B (HMBC). 
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Fig. 11. Lygosteroside B (HMBC). 
  
Fig. 12. Lygosteroside B  (1H-1H COSY). 
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Fig. 13. Lygosteroside B  (NOESY).  
 
Fig. 14. Lygosteroside B  (NOESY). 
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Fig. 15. Lygosteroside B (ESI). 
3.3 The new compound 3 from Lygodium [7] 
OH
HO
O
O
OH
Glc
O
O
 
lygodiumsteroside A 
3.3.1 Extraction and isolation 
The air-dried roots of L. japonicum (Thunb.) Sw. (4 kg) were crushed and extracted twice 
under reflux with 70% EtOH. The solution was concentrated under reduced pressure to 
obtain the residue, and then the residue was extracted with MeOH. The MeOH-soluble 
fraction (100 g) was isolated by column chromatography on silica gel using gradient elution 
with CHCl3–MeOH (50:1 to 1:1), which gave 14 fractions. Fraction 9 (10 g) was subjected to 
silica gel column chromatography using CHCL3–MeOH(40:1 to1:1) in gradient to give 
fractions 1–4. Fraction 4 (3.7 g) was chromatographed on an ODS column eluting with 
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MeOH–H2O system, giving two fractions. Fraction 2 (1.3 g) was isolated by a semi-
preparative ODS column using MeOH–H2O (65:35) as the eluent to afford lygodium A (9 
mg) and a kown compound ponastteroside A(30 mg), respectively. 
3.3.2 Apparatus 
Melting points were determined on an X4-A micro-melting point apparatus and were 
uncorrected. ESI-MS spectra were measured on an Agilent1100 LC-MSD-Trap-SL, and HR-
ESI-MS spectra were measured on a Bruker Daltonics MicroTOFQ. NMR spectra were 
measured on a Bruker ARX-600 NMR spectrometer with tetramethylsilane (TMS) as the 
internal reference and chemical shifts are expressed with δ (ppm). UV spectra were 
recorded on a Shimadzu UV-2201 spectrometer. IR spectra were recorded on a Bruker IFS-55 
spectrophotometer. TLC was performed on silica gel GF254 (10–40 l; Qingdao, 
China).Separation was performed by semiprep HPLC using Shimadzu SPD-10A apparatus 
equipped with a UV detector under an ODS column (i.d. 10 mm * 200 mm). 
3.3.3 The spectrum of new compound 
1. NMR data (nuclear magnetic resonance) of lygodiumsteroside A 
 
C No. HMQC HMBC 
δC(ppm) DEPT δH(ppm) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
38.0 (t) 
66.8 (d) 
77.1 (d) 
29.9 (t) 
50.7 (d) 
202.3 (s) 
121.1 (d) 
165.4 (s) 
33.5 (d) 
38.4 (s) 
20.3 (t) 
31.2 (t) 
47.2 (d) 
83.4 (s) 
31.1 (t) 
20.7 (t) 
49.2 (d) 
17.3 (q) 
23.4 (q) 
75.1 (s) 
20.7 (q) 
85.3 (d) 
1.72(t, J=12.6 Hz), 2.05(m) 
4.06(br.dt, J=11.4 Hz), 
4.29(brs) 
1.66, 2.16(each m) 
2.90(m) 
 
6.18(brs) 
 
3.50(brt) 
 
1.64, 1.77(each m) 
1.86, 2.57(each m) 
 
 
1.86, 2.12(each m) 
2.05, 2.39(each m) 
2.93(m) 
1.09(s) 
0.86(s) 
 
1.44(s) 
4.44(dd, J=11.5Hz and 2.5Hz)
C-2,C-3,C-9,C-10,C-19 
 
 
 
C-4,C-9 
 
C-5,C-9,C-14 
 
 
 
C-8,C-9,C-10,C-12 
C-9,C-11,C-13,C-18 
 
 
C-14,C-16,C-17 
C-17 
C-13,C-16,C-18 
C-12,C-13,C-14,C-17 
C-2,C-5,C-9,C-10 
 
C-17, C-20, C-22 
C-23,C-24 
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C No. HMQC HMBC 
δC(ppm) DEPT δH(ppm) 
23 
24 
25 
26 
27 
28 
29 
C-1′ 
C-2′ 
C-3′ 
C-4′ 
C-5′ 
C-6′ 
29.0 (t) 
39.5 (d) 
40.7 (d) 
173.9 (s) 
15.2 (q) 
25.9 (t) 
9.6 (q) 
103.5 (d) 
74.0 (d) 
78.0 (d) 
70.9 (d) 
77.8 (d) 
61.9 (t) 
1.41, 2.05(each m) 
1.41(m) 
2.17(m) 
 
1.28(d, J=7.2Hz) 
1.01,1.37(each m) 
0.67(t, J=7.2Hz) 
4.89(d, J=7.8Hz) 
4.01(t-like) 
4.18(overlap) 
4.06(overlap) 
3.90(t-like) 
4.31(m), 4.49(brd, J=11.5Hz) 
C-24,C-25,C-28 
 
C-24,C-27,C-28 
 
C-24,C-25,C-26 
C-23,C-24,C-29 
C-24,C-28 
C-3 
C-3′ 
C-2′, C-4′ 
C-5′, C-6′ 
C-4′, C-5′ 
C-4′, C-5′ 
Table 4. 1H and 13C NMR data for lygodiumsteroside A (600 and 150 MHz, in C5D5N). 
2. Correlative spectrum data: 
O
O
OH
HO
O
O
OH
HO
OH
OH
OH
HO
H
 
Fig. 16. The key correlations of the new compound 3. 
3. Analysis and conclusions of the new compound 3: 
The new compound 3,white powder, mp.245–246℃, gave positive response to Liebermann–
Burchard reaction and Molish reaction, suggesting a steroid glycoside structure. The sugar 
was identified as glucose by co-TLC with authentic sample after acid hydrolysis. 
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The molecular formula was determined as C35H54O12 by HR-ESI-MS (m/z 701.3309 [M+CL]-, 
calcd. 701.3309), along with 1H-NMR and 13C-NMR data. Additionally, the UV spectrum of 
compound 1 showed a maximum at  λ = 243 nm and the IR spectrum exhibited absorption at 
1,730 cm-1for an a, b-unsaturated carbonyl group. The 1H-NMR (600 MHz, C5D5N) spectrum 
showed an olefinic proton at δ6.18 (1H, brs, H-7) and five methyl signals at δ1.44 (3H, s, H-
21), 1.28 (3H, d, J = 7.2 Hz,H-27), 1.09 (3H, s, H-18), 0.86 (3H, s, H-19), 0.67 (3H, t,J = 7.2 
Hz,H-29). The 13C-NMR (150 MHz, C5D5N) showed five methyl signals and a typical a, ͊-
unsaturated carbonyl group signals atδ 202.3 (C-6), 165.4 (C-8), and 121.1 (C-7), which 
revealed an ecdysteroid-type nucleus. It was also confirmed by the HMBC correlations of 
the new compound 3 . In the HSQC spectrum, δ4.06 (1H, brd,J = 11.4 Hz, H-2) andδ 4.29 
(1H, brs, H-3) had direct correlation with δ 66.8 (C-2) and δ 77.1 (C-3), respectively, which 
combined with the information of long correlation in the HMBC spectrum—d 1.44 (3H, s, H-
21) correlated with d 49.2 (C-17), d 85.2 (C-22), andδ 75.1 (C-20), respectively—all of these 
signals elucidated the presence of five hydroxyl carbons C-2, C-3, C-14, C-20, and C-22. 
Additionally, δ 1.09 (3H, s, H-18) and δ1.44(3H, s, H-21), d 2.17 (1H, m, H-25) and δ1.28 
(3H, d,J = 7.2 Hz, H-27), δ 2.93 (1H, m, H-17) andδ 2.05, 2.39(2H, each m, H-16) correlated 
mutually with each other in the 2D- COSY spectrum. The occurrence of ͉-͊lactone ring in 
the side chain was evidenced by the carbonyl absorption at 1,730 cm-1in the IR and the δ 
173.9 ppm in the13C-NMR. The HMBC spectrum showed the long correlation between the 
methyl proton signal at δ1.28 (3H, d,J = 7.2 Hz, H-27) and the carbon signals at δ39.5 (C-
24),40.7 (C-25), and 173.9 (C-26). The correlation between the methyl proton signal at δ 0.67 
(3H, t, J = 7.2 Hz, H-29) and the carbon signals at δ 25.9 (C-28), 39.5 (C-24), and the 
correlation between the methyl proton signal at δ2.19 (1H, m, H-25) and the carbon signals 
atδ 15.2 (C-27), 25.9 (C-28), and 39.5 (C-24) could be observed, respectively. Moreover , 
δ4.44 (1H, dd, J = 11.5 Hz and 2.5 Hz, H-22)also showed the correlation with δ29.0 (C-23), 
39.5 (C-24)in the HMBC. Taken together, the structure of the side chain was identified. The 
HMBC correlation was observed between the anomeric proton signal at δ 4.89 (1H, d, H-10) 
and the carbon signal at d 77.1 due to C-3 of the aglycone moiety. This key long-range cross 
peak fixed the glycosidation position.The chemical shifts of the sugar moiety in 13C-NMR 
(δ103.5, 74.0, 78.0, 70.9, 77.8, 61.9) also confirmed the presence of B-glucopyranose. The 
anomeric configuration of glucose was determined to be on the basis of the JH–H values (J = 
7.8 Hz) and d 4.09 (1H, brs, H-3) correlated with d 4.85 (1H, d, anomeric proton) in the NOE 
spectrum. (The NOESY spectra mentioned in this text was recorded in CD3OD because the 
key proton signals overlapped in C5D5N). The relative configuration of the new compound 3 
was identified by the NOESY correlation between the proton signal atδ 4.09 (1H, brs, H-3) 
and δ3.85 (1H, brd, H-2), δ1.87 (1H, m, Ha-4). Careful comparison 13C-NMR data of the 
new compound 3 and a known compound, named capitasterone[8][9], revealed that the B, C, 
and D rings and the side chain were very similar to that of capitasterone. Furthermore, the 
stereochemistry of C-20 and C-22 of capitasterone had established R, in the NOE spectrum 
(in CD3OD) of he new compound 3, δ4.25 (1H, dd, J = 11.5 Hz and 2.5 Hz, H-22) had 
correlated with δ1.56 (1H, m, H-24);however, d 1.56 (1H, m, H-24) never correlated with d 
2.17 (1H, m, H-25). All of these confirmed the stereochemistry of C24 and C25 as R and S, 
respectively. The 1H-NMR and13C-NMR signals of the aglycone moiety of he new 
compound 3 were found to be similar to that of capitasterone .Therefore, the structure of he 
new compound 3 was elucidated safely as Lygodiumsteroside A (Fig. 15). 
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Fig. 17. Lygosteroside A (1H-NMR, in C5D5N).  
 
Fig. 18. Lygosteroside A (13C-NMR, in C5D5N). 
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Fig. 19. Lygosteroside A  (DEPT).  
 
Fig. 20. Lygosteroside A  (HSQC, in C5D5N). 
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Fig. 21. Lygosteroside A (HSQC, in C5D5N).  
 
Fig. 22. Lygosteroside A  (HMBC, in C5D5N). 
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Fig. 23. Lygosteroside A  (HMBC, in C5D5N).  
 
Fig. 24. Lygosteroside A (HMBC, in C5D5N). 
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Fig. 25. Lygosteroside A (HSQC, in MeOH).  
  
Fig. 26. Lygosteroside A  (HSQC, in MeOH). 
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Fig. 27. Lygosteroside A  (NOESY, in MeOH).  
  
Fig. 28. Lygosteroside A  (ESI). 
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4. Pharmacological actions 
4.1 Antibacterial action[10] 
Inhibiting Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi and shigella  
Flexneri. 
4.2 Antivirus[11] 
Water extract and alcohol extract of Lygodium spores both can inhibit HIV-1 virus. The 
Concertration of water extract above 125ug/ml can wholly inhibit HIV-1 virus. 
4.3 Resistance to male hormone and effect on hair growth[12] 
50% alcohol extract of Lygodium Spores can inhibit the activity of Testosterone 5-α reduct-
ase in vitro and activate hair follicle. 
4.4 Normalizing functioning of the gallbladder and dissolving stone[13]  
4.5 Liver protection[14]  
The water extract of Lygodium (50ug/ml) can significantly reduce the GPT action of liver 
Cell cultures containing GaIN 5*10~3mol/L,so it has effect on liver protection markably. 
4.6 Cure urinary impassability, tumescent feeling below umbilicus, 
4.7 Urgent pain:Lygodium powder drinking by licorice soup. 
4.8 Have a good effect on urinary tract infection, urinary calculus, nephritis edema, cold 
with fever ,urine content small and cardial, enteritis diarrhea. 
5. Indications[10] 
5.1 Stranguria marked by chyluria, stranguria caused by the passage of urinary stone, stranguria  
from urolithiasis and strangury due to heat. For dribling and painful micturition , there is 
powder of climbing fern spore from standards of diagnosis and treament: Climbing fern 
spore 6g,red poria 9g, umbellate pore-fungus 9g, white atractylodes rhizome 9g,peony root 9g, 
oriental water plantain rhizome 15g, talc 21g, pyrrosia leaf 3g. Grind these herbs into a fine  
powder. Take 9g each time. For stranguria marked by chyluria ,there is powder of climbing  
fern spore: Climbing fern spore 30g, talc 30g, licorice root 7.5g. Grind these herbs into a fine  
powder.Take 6g each time. 
5.2 Dampness in the spleen, general edema, distension in the abdomen can be treated with 
powder of fern spore from Inventions of medicine: Morning glory seed 45g, kansui root 15g 
climbing fen spore 15g, grind these herbs into a fine powder. Take 6g each time before 
meals. 
6. Conclusion 
Lygodium japonicum (Thunb.)Sw., which belongs to the genus Lygodium of the family 
Lygodiaceae, is the dry root and rhizome of Lygodium japonicum (Thunb.)Sw. There are 
different constituents in different parts of it and distribution of content of these constituents 
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are different.The paper aims at making a systematical research for the root of Lygodium 
japonicum (Thunb.)Sw. that is one specie of medicinal Lygodium. According to the existing 
literature, the main constituents of Lygodium are steroidal, flavonoids, organic acids and 
other substances, but it is no clear whether all these chemical constituents are effective 
composition or not. 
This paper summarize the research on chemical constituents and pharmacological actions of 
Lygodium, . From our systematic research on Lygodium, we have isolated and identified 
many kinds of compounds. In this paper, we focus on introduction of three new 
compounds: lygodiumsteroside A and lygodiumsteroside B and 2-isopropyl-7-methyl-6-
hydroxy-α- (1,4) naphthoquinone, as well as the data analysis of UV, IR, 1H-NMR, 13C-
NMR、2D-NMR and HR-MS. We also generalize pharmacological actions and clinical 
applications of Lygodium. 
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